The cloudy truth about ‘blue zones’

• by Torie Bosch

• May 16, 2026

Tirofiban After Tenecteplase in Stroke

Adjunctive tirofiban was linked to higher rates of positive 90-day outcomes in acute ischemic stroke.

• by Kathryn Wighton

• May 14, 2026

• 6 min

Tenecteplase Prior to EVT Did Not Improve Stroke Outcomes

Phase 3 trial leaves open the possibility of clinically meaningful benefit or harm in selected late-window patients.

• by Kathryn Wighton

• May 14, 2026

• 6 min

The Chronic Disease Conundrum

Russ Lebovitz and Arnon Chait on why we need smarter biomarkers to guide clinically actionable diagnostics in an aging population

• by Jessica Allerton

• May 14, 2026

• 7 min